SCHEMBL12872677

SCHEMBL12872677

Cc1c(Br)cc(/C=N/NC(=O)CN(CC(=O)O)c2ccc3ccccc3c2)c(O)c1Br

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 1/20 0.52
▸ SIRT1 Q96EB6 9/20 0.48
▸ FTO Q9C0B1 1/20 0.44
▸ SIRT2 Q8IXJ6 1/20 0.43
▸ SIRT3 Q9NTG7 1/20 0.43
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ KDM4E B2RXH2 4/20 0.41
▸ HTT P42858 4/20 0.41
▸ LMNA P02545 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ MAPT P10636 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ OXTR P30559 1/20 0.40
▸ RAB9A P51151 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ ALOX12 P18054 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12872691 0.92 CFTR (0.51) CFTRSIRT1FTOSIRT2SIRT3
SCHEMBL12872676 0.91 CFTR (0.52) CFTRSIRT1FTOSIRT2SIRT3
SCHEMBL12594719 0.85 CFTR (0.61) CFTRSIRT1FTOSIRT2SIRT3
SCHEMBL12594745 0.85 CFTR (0.61) CFTRSIRT1FTOSIRT2SIRT3
SCHEMBL14082249 0.84 CFTR (0.45) CFTRSIRT1FTOSIRT2SIRT3
SCHEMBL12594724 0.83 CFTR (0.61) CFTRSIRT1FTOSIRT2SIRT3
SCHEMBL12887923 0.81 CFTR (0.58) CFTRSIRT1FTOSIRT2SIRT3
SCHEMBL12594732 0.80 CFTR (0.57) CFTRSIRT1FTOSIRT2SIRT3
SCHEMBL12594765 0.79 CFTR (0.56) CFTRSIRT1FTOSIRT2SIRT3
SCHEMBL12594706 0.79 CFTR (0.55) CFTRSIRT1FTOSIRT2SIRT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7888332-B2 Hydrazide-containing CFTR inhibitor compounds and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-02-15 — — US disclosed
US-7414037-B2 cystic fibrosis transmembrane conductance regulator protein inhibitor; 2-naphthalenylamino-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene][3-[4-(3-(PEG)n-thioureido)diphenyl)-thioureido]propanedioic acid dihydrazide (MalH-(PEG)nB); cystic fibrosis with forms of male infertility, secretory diarrhea THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-08-19 — — US disclosed
Send feedback